Dilated phase of hypertrophic cardiomyopathy: high-risk reconstructive surgery as an alternative to heart transplantation

The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Search result: 0

Dzemeshkevich S.L.

Petrovsky Russian Scientific Center of Surgery

Motreva A.P.

Petrovsky Russian Scientific Center of Surgery

Kalmykova O.V.

Petrovsky Russian Scientific Center of Surgery

Martyanova Yu.B.

Federal Center for Cardiovascular Surgery

Tarasov D.G.

Federal Center for Cardiovascular Surgery;
Astrakhan State Medical University

Dombrovskaya A.V.

Petrovsky Russian Scientific Center of Surgery

Zaklyazminskaya E.V.

Acad. B.V. Petrovsky Russian Scientific Center for Surgery

Dilated phase of hypertrophic cardiomyopathy: high-risk reconstructive surgery as an alternative to heart transplantation

Authors:

Dzemeshkevich S.L., Motreva A.P., Kalmykova O.V., Martyanova Yu.B., Tarasov D.G., Dombrovskaya A.V., Zaklyazminskaya E.V.

More about the authors

Journal: Pirogov Russian Journal of Surgery. 2021;(6‑2): 31‑36

DOI: 10.17116/hirurgia202106231

Views: 2107

Downloaded: 53

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Dzemeshkevich SL, Motreva AP, Kalmykova OV, Martyanova YuB, Tarasov DG, Dombrovskaya AV, Zaklyazminskaya EV. Dilated phase of hypertrophic cardiomyopathy: high-risk reconstructive surgery as an alternative to heart transplantation. Pirogov Russian Journal of Surgery. 2021;(6‑2):31‑36. (In Russ.)
https://doi.org/10.17116/hirurgia202106231

Подписка 2025-2 (Pirogov Russian Journal of Surgery)

Close metadata

Recommended articles:

Redo surgical treatment of a patient with hypertrophic cardiomyopathy and recurrent left ventricular outflow tract obstruction. Pirogov Russian Journal of Surgery. 2025;(2):123-127

Surgical treatment of mid-ventricular hypertrophic obstructive cardiomyopathy with apical aneurysm. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(5):545-549

Left ventricular myocardial mass index as a predictor of spontaneous rhythm recovery after cardioplegia in patients with obstructive hypertrophic cardiomyopathy. Russian Journal of Anesthesiology and Reanimatology. 2024;(6):30-37

Long-term outcomes after ethanol septal ablation in the treatment of patients with hypertrophic cardiomyopathy. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(1):23-27

Ex vivo coronary angiography using hearts from older donors. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(1):66-72

Analysis of differential gene expression in myocardial tissue from patients with hypertrophic cardiomyopathy. Molecular Genetics, Microbiology and Virology. 2025;(1):17-23

Clinical manifestation of apical hypertrophic cardiomyopathy by syncope in the elderly. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(2):237-243

The authors report the diagnosis and surgical treatment of 5 patients with dilated phase of hypertrophic cardiomyopathy (HCM). Features of these patients are progressive heart failure, double-level blood flow obstruction and the risk of apical aneurysms. Reconstructive remodeling surgery is a reasonable alternative to heart transplantation despite the existing risk.

Keywords:

hypertrophic cardiomyopathy

dilated phase

heart transplantation

myectomy

Authors:

Dzemeshkevich S.L.

Petrovsky Russian Scientific Center of Surgery

Motreva A.P.

Petrovsky Russian Scientific Center of Surgery

Kalmykova O.V.

Petrovsky Russian Scientific Center of Surgery

Martyanova Yu.B.

Federal Center for Cardiovascular Surgery

Tarasov D.G.

Federal Center for Cardiovascular Surgery;
Astrakhan State Medical University

Dombrovskaya A.V.

Petrovsky Russian Scientific Center of Surgery

Zaklyazminskaya E.V.

Acad. B.V. Petrovsky Russian Scientific Center for Surgery

Received:

15.04.2021

Accepted:

29.04.2021

List of references:

Semsarian C, Ingles J, Maron MS, Maron BJ. New perspective on the prevalence of hypertrophic cardiomyopathy. Journal of the American College of Cardiology. 2015;65(12):1249-1254. https://doi.org/10.1016/j.jacc.2015.01.019
Ommen SR, Mital S, Burke MA, Day SM, Deswal A, Elliott P, Evanovich LL, Hung J, Joglar JA, Kantor P, Kimmelstiel C, Kittleson M, Link MS, Maron MS, Martinez MW, Miyake CY, Schaff HV, Semsarian C, Sorajja P. 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2020;142(25):533-557. https://doi.org/10.1161/CIR.0000000000000938
Biagini E, Coccolo F, Ferlito M, Perugini E, Rocchi G, Bacchi-Reggiani L, Lofiego C, Boriani G, Prandstraller D, Picchio FM, Branzi A, Rapezzi C. Dilated — hypertrophic evolution of hypertrophic cardiomyopathy. Prevalence, incidence, risk factors and prognostic implication in pediatric and adult patients. Journal of the American College of Cardiology. 2005;46(8):1543-1550. https://doi.org/10.1016/j.jacc.2005.04.062
Sato A, Sakamoto N, Ando K, Kaneshiro T, Uekita H, Sugimoto K, Yamaki T, Kunii H, Nakazato K, Suzuki H, Saitoh S, Sato M, Tamagawa K, Arimura T, Kimura A, Takeishi Y. Dilatedphase of hypertrophic cardiomyopathy caused by two different sarcomere mutations treated with surgical left ventricular reconstruction and cardiac resynchronization therapy with a defibrillator. Internal Medicine. 2012;51(18):2559-2564. https://doi.org/10.2169/internalmedicine.51.7684
Harris KM, Spirito P, Maron MS, Zenovich AG, Formisano F, Lesser JR, Mackey-Bojack S, Manning WJ, Udelson JE, Maron BJ. Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy. Circulation. 2006;114(3):216-225. https://doi.org/10.1161/CIRCULATIONAHA.105.583500
Dzemeshkevich S, Korolev S, Frolova J, Skridlevskaya E, Margolina A, Podlesskich Y, Sinitsin V, Akchurin R. Isolated replacement of the mitral leaflets and “Mercedes”-plastics of the giant left atrium: surgery for patients with left ventricle dysfunction and left atrium enlargement. The Journal of Cardiovascular Surgery. 2001;42(4):505-508.
Schaff HV, Brown ML, Dearani JA, Abel MD, Ommen SR, Sorajja P, Tajik AJ, Nishimura RA. Apical myectomy: a new surgical technique for management of severely symptomatic patients with apical hypertrophic cardiomyopathy. The Journal of Thoracic and Cardiovascular Surgery. 2010;139(3):634-640. https://doi.org/10.1016/j.jtcvs.2009.07.079
Maron B.J. Hypertrophic cardiomyopathy: a systematic seview. Journal of the American Medical Association. 2002;287(10):1308-1320. https://doi.org/10.1001/jama.287.10.1308
Norrish G, Jager J, Field E, Quinn E, Fell H, Lord E, Cicerchia MN, Ochoa JP, Cervi E, Elliott PM, Kaski JP. Yield of clinical screening for hypertrophic cardiomyopathy in child first-degree relatives. Circulation. 2019;140(3):184-192. https://doi.org/10.1161/CIRCULATIONAHA.118.038846

Close metadata

Log in to the site using your account in one of the services

Registration

Last Name

Name

Middle Name

E-mail

Phone

Address

Country

Zip

City

Region

Street

Home

Apartmen

Legal entity name

ИНН

КПП

Password

Password

Repeat password

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.